

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tolerance induction (GO:0002507) | 7.76518299 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.29995016 |
| 3 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.16378223 |
| 4 | negative T cell selection (GO:0043383) | 7.09630482 |
| 5 | negative regulation of cell killing (GO:0031342) | 7.01158181 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.01158181 |
| 7 | negative thymic T cell selection (GO:0045060) | 6.88409017 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.63564700 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.06657920 |
| 10 | regulation of regulatory T cell differentiation (GO:0045589) | 6.03355998 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.80786778 |
| 12 | response to interleukin-15 (GO:0070672) | 5.73568680 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 5.70679368 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.44456459 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.44089373 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 5.39028938 |
| 17 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.35788743 |
| 18 | regulation of T cell tolerance induction (GO:0002664) | 5.34057244 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.25741155 |
| 20 | thymic T cell selection (GO:0045061) | 5.25033622 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.18557609 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 5.18044188 |
| 23 | T cell selection (GO:0045058) | 5.04676270 |
| 24 | positive regulation of tolerance induction (GO:0002645) | 4.83942621 |
| 25 | positive T cell selection (GO:0043368) | 4.70177959 |
| 26 | T cell migration (GO:0072678) | 4.60255196 |
| 27 | regulation of tolerance induction (GO:0002643) | 4.58438843 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.53368846 |
| 29 | activated T cell proliferation (GO:0050798) | 4.49707527 |
| 30 | leukocyte aggregation (GO:0070486) | 4.46507651 |
| 31 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.46262676 |
| 32 | positive thymic T cell selection (GO:0045059) | 4.44637217 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.25406969 |
| 34 | positive regulation of granulocyte differentiation (GO:0030854) | 4.21122524 |
| 35 | T cell receptor signaling pathway (GO:0050852) | 4.04293231 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.96831272 |
| 37 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.94504256 |
| 38 | interferon-gamma production (GO:0032609) | 3.93670163 |
| 39 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.86332864 |
| 40 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.84509214 |
| 41 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.81747507 |
| 42 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.78591901 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.78249284 |
| 44 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.76941408 |
| 45 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.76941408 |
| 46 | alpha-beta T cell differentiation (GO:0046632) | 3.74243219 |
| 47 | T cell homeostasis (GO:0043029) | 3.70832878 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 3.64481999 |
| 49 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.63320284 |
| 50 | regulation of B cell differentiation (GO:0045577) | 3.61731948 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 3.55135428 |
| 52 | positive regulation of humoral immune response (GO:0002922) | 3.52231848 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 3.51214143 |
| 54 | positive regulation of interleukin-4 production (GO:0032753) | 3.50321227 |
| 55 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.45917003 |
| 56 | alpha-beta T cell activation (GO:0046631) | 3.41982553 |
| 57 | cellular response to type I interferon (GO:0071357) | 3.38929845 |
| 58 | type I interferon signaling pathway (GO:0060337) | 3.38929845 |
| 59 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.38208055 |
| 60 | mast cell activation (GO:0045576) | 3.37461996 |
| 61 | regulation of defense response to virus by virus (GO:0050690) | 3.36672182 |
| 62 | response to type I interferon (GO:0034340) | 3.35827642 |
| 63 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.33669523 |
| 64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.33329383 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.32099731 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 3.32099731 |
| 67 | positive regulation by symbiont of host defense response (GO:0052509) | 3.32099731 |
| 68 | modulation by symbiont of host defense response (GO:0052031) | 3.32099731 |
| 69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.32099731 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.32099731 |
| 71 | T cell costimulation (GO:0031295) | 3.31622766 |
| 72 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.31307087 |
| 73 | detection of bacterium (GO:0016045) | 3.29354465 |
| 74 | lymphocyte costimulation (GO:0031294) | 3.28084599 |
| 75 | detection of other organism (GO:0098543) | 3.27209659 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.26214627 |
| 77 | regulation of isotype switching (GO:0045191) | 3.25014186 |
| 78 | positive regulation of interleukin-2 production (GO:0032743) | 3.24149301 |
| 79 | negative regulation of B cell mediated immunity (GO:0002713) | 3.19800949 |
| 80 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.19800949 |
| 81 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.19231877 |
| 82 | T cell differentiation (GO:0030217) | 3.18468956 |
| 83 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.18061611 |
| 84 | negative regulation of adaptive immune response (GO:0002820) | 3.17174689 |
| 85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13068187 |
| 86 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.11930463 |
| 87 | cellular extravasation (GO:0045123) | 3.11656612 |
| 88 | lymphocyte migration (GO:0072676) | 3.11164716 |
| 89 | regulation of alpha-beta T cell activation (GO:0046634) | 3.10130859 |
| 90 | regulation of cell killing (GO:0031341) | 3.08014984 |
| 91 | positive regulation of isotype switching (GO:0045830) | 3.06952933 |
| 92 | myeloid dendritic cell differentiation (GO:0043011) | 3.06587147 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06371833 |
| 94 | positive regulation of cell killing (GO:0031343) | 3.05391267 |
| 95 | positive regulation of T cell mediated immunity (GO:0002711) | 3.04619751 |
| 96 | neutrophil activation involved in immune response (GO:0002283) | 3.01884311 |
| 97 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.01057320 |
| 98 | regulation of T cell mediated immunity (GO:0002709) | 3.00686411 |
| 99 | regulation of interleukin-4 production (GO:0032673) | 2.99952501 |
| 100 | dendritic cell chemotaxis (GO:0002407) | 2.99717310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.48277637 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.61186698 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.02819971 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.98157532 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.60625688 |
| 6 | MYB_26560356_Chip-Seq_TH2_Human | 3.52873081 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37045097 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.32166808 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.28147660 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.21713475 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.13830425 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.03158008 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.94012832 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92043673 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.91596126 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.78669135 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.76717041 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57156351 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.56437034 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.37727836 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.33158900 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.32427303 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.31630955 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 2.29312044 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28664708 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25499745 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21667344 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.19028069 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01440539 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95348581 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90574968 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87190950 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86828319 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.81071759 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.81024060 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74369316 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73877038 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73014351 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71827617 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70756541 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68549210 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66370392 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65712532 |
| 44 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.64432471 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63788674 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62677736 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53590532 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47527166 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.44969705 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40989007 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.37838605 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37321941 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34933858 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33755125 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32493808 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30122029 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26373257 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25152215 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24870392 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23270900 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21559213 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21328505 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20813862 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20617821 |
| 65 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20553980 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15699167 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12582764 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11470691 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10036134 |
| 70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09480947 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02039608 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01698382 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01288214 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01169664 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01162723 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00466890 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00057732 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98869101 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95871548 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94283530 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91952359 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91081325 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89135006 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86895557 |
| 85 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86615901 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85029534 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83829974 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80591342 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.80005467 |
| 90 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79995363 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77360952 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75715684 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74085100 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71769781 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.70686032 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.68916337 |
| 97 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68434137 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67445303 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.66489947 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.65300418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.93807704 |
| 2 | MP0005671_abnormal_response_to | 4.44953813 |
| 3 | MP0003436_decreased_susceptibility_to | 3.64912501 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.48821318 |
| 5 | MP0001800_abnormal_humoral_immune | 3.35321372 |
| 6 | MP0003724_increased_susceptibility_to | 3.21247195 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.19971979 |
| 8 | MP0001873_stomach_inflammation | 3.13583097 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 3.03377283 |
| 10 | MP0000685_abnormal_immune_system | 2.90358979 |
| 11 | MP0001790_abnormal_immune_system | 2.87518731 |
| 12 | MP0005387_immune_system_phenotype | 2.87518731 |
| 13 | MP0002723_abnormal_immune_serum | 2.76722791 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.74195763 |
| 15 | MP0001819_abnormal_immune_cell | 2.70182102 |
| 16 | MP0005025_abnormal_response_to | 2.62686470 |
| 17 | MP0009785_altered_susceptibility_to | 2.62504124 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.58637356 |
| 19 | MP0003866_abnormal_defecation | 2.53774445 |
| 20 | MP0000703_abnormal_thymus_morphology | 2.52741412 |
| 21 | MP0002398_abnormal_bone_marrow | 2.45399237 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.43001464 |
| 23 | MP0002405_respiratory_system_inflammati | 2.40831460 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.39476049 |
| 25 | MP0002419_abnormal_innate_immunity | 2.35887088 |
| 26 | MP0003303_peritoneal_inflammation | 2.34157838 |
| 27 | MP0000716_abnormal_immune_system | 2.23473116 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.16051585 |
| 29 | MP0004381_abnormal_hair_follicle | 2.11904240 |
| 30 | MP0006082_CNS_inflammation | 2.09801633 |
| 31 | MP0004947_skin_inflammation | 2.03611761 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 2.01957143 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 2.01450759 |
| 34 | MP0002722_abnormal_immune_system | 2.01012020 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.99707728 |
| 36 | MP0005310_abnormal_salivary_gland | 1.94897381 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.85094388 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.75327187 |
| 39 | MP0002429_abnormal_blood_cell | 1.75064528 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.72170587 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.72162052 |
| 42 | MP0001348_abnormal_lacrimal_gland | 1.70629319 |
| 43 | MP0008260_abnormal_autophagy | 1.57947457 |
| 44 | MP0001851_eye_inflammation | 1.56123847 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.52679101 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.46856425 |
| 47 | MP0002163_abnormal_gland_morphology | 1.45607721 |
| 48 | MP0001853_heart_inflammation | 1.33437281 |
| 49 | MP0008469_abnormal_protein_level | 1.27139721 |
| 50 | MP0002006_tumorigenesis | 1.19066769 |
| 51 | MP0002933_joint_inflammation | 1.18265767 |
| 52 | MP0000490_abnormal_crypts_of | 1.17103947 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.09962581 |
| 54 | MP0002132_abnormal_respiratory_system | 1.09663664 |
| 55 | MP0002009_preneoplasia | 1.06234548 |
| 56 | MP0009764_decreased_sensitivity_to | 1.01328009 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 0.99382841 |
| 58 | MP0001663_abnormal_digestive_system | 0.99135752 |
| 59 | MP0003045_fibrosis | 0.98151956 |
| 60 | MP0000858_altered_metastatic_potential | 0.97099186 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 0.86881435 |
| 62 | MP0009763_increased_sensitivity_to | 0.85495284 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.84572462 |
| 64 | MP0009278_abnormal_bone_marrow | 0.83264311 |
| 65 | MP0003828_pulmonary_edema | 0.79566881 |
| 66 | MP0005451_abnormal_body_composition | 0.78233696 |
| 67 | MP0004883_abnormal_blood_vessel | 0.77161480 |
| 68 | MP0004510_myositis | 0.76911579 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.75411456 |
| 70 | MP0002693_abnormal_pancreas_physiology | 0.74639704 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.74281329 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 0.72285777 |
| 73 | MP0003448_altered_tumor_morphology | 0.68907384 |
| 74 | MP0000604_amyloidosis | 0.65754611 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.64193436 |
| 76 | MP0004130_abnormal_muscle_cell | 0.64141947 |
| 77 | MP0005166_decreased_susceptibility_to | 0.62392877 |
| 78 | MP0003091_abnormal_cell_migration | 0.60303409 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.57640982 |
| 80 | MP0001919_abnormal_reproductive_system | 0.57184993 |
| 81 | MP0001346_abnormal_lacrimal_gland | 0.55993377 |
| 82 | MP0005381_digestive/alimentary_phenotyp | 0.54368742 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.54012468 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.52893482 |
| 85 | MP0005390_skeleton_phenotype | 0.51598394 |
| 86 | MP0003795_abnormal_bone_structure | 0.50637634 |
| 87 | MP0000249_abnormal_blood_vessel | 0.49415359 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48569317 |
| 89 | MP0005164_abnormal_response_to | 0.47051614 |
| 90 | MP0008057_abnormal_DNA_replication | 0.45537487 |
| 91 | MP0002254_reproductive_system_inflammat | 0.45236115 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.44821972 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.44821972 |
| 94 | MP0008874_decreased_physiological_sensi | 0.41671244 |
| 95 | MP0000371_diluted_coat_color | 0.41618919 |
| 96 | MP0008569_lethality_at_weaning | 0.40996137 |
| 97 | MP0000609_abnormal_liver_physiology | 0.40756622 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.39778937 |
| 99 | MP0003787_abnormal_imprinting | 0.37275954 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.36709205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 6.97070109 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.41503893 |
| 3 | T lymphocytopenia (HP:0005403) | 6.25984267 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.94560535 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.86542129 |
| 6 | Autoimmune hemolytic anemia (HP:0001890) | 5.56131504 |
| 7 | Myositis (HP:0100614) | 5.09647374 |
| 8 | Abnormality of T cells (HP:0002843) | 4.92407600 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.47026185 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.40885245 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.39693571 |
| 12 | IgG deficiency (HP:0004315) | 4.38789227 |
| 13 | Severe combined immunodeficiency (HP:0004430) | 4.38687387 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 4.33106648 |
| 15 | Optic neuritis (HP:0100653) | 4.33106648 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.30591027 |
| 17 | IgM deficiency (HP:0002850) | 4.29810061 |
| 18 | Orchitis (HP:0100796) | 4.25051606 |
| 19 | Increased IgM level (HP:0003496) | 3.97736077 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.93576701 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.86312587 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.83660429 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.81267816 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.81071872 |
| 25 | Vasculitis (HP:0002633) | 3.70427230 |
| 26 | Meningitis (HP:0001287) | 3.62382485 |
| 27 | Encephalitis (HP:0002383) | 3.53562431 |
| 28 | Abnormality of eosinophils (HP:0001879) | 3.52209215 |
| 29 | Obstructive lung disease (HP:0006536) | 3.50195084 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.50195084 |
| 31 | Combined immunodeficiency (HP:0005387) | 3.49165597 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.48776056 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.48776056 |
| 34 | Leukocytosis (HP:0001974) | 3.45313578 |
| 35 | Pustule (HP:0200039) | 3.44407086 |
| 36 | Pulmonary infiltrates (HP:0002113) | 3.40343091 |
| 37 | Lymphopenia (HP:0001888) | 3.39385226 |
| 38 | Granulocytopenia (HP:0001913) | 3.39131027 |
| 39 | Recurrent viral infections (HP:0004429) | 3.26932939 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 3.25701361 |
| 41 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.24833157 |
| 42 | Recurrent skin infections (HP:0001581) | 3.24738096 |
| 43 | Eosinophilia (HP:0001880) | 3.23762936 |
| 44 | Spontaneous hematomas (HP:0007420) | 3.20023973 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 3.19462057 |
| 46 | Increased IgE level (HP:0003212) | 3.17944719 |
| 47 | Chronic diarrhea (HP:0002028) | 3.13511815 |
| 48 | Abnormality of B cell number (HP:0010975) | 3.10384841 |
| 49 | B lymphocytopenia (HP:0010976) | 3.09811670 |
| 50 | Keratoconjunctivitis (HP:0001096) | 3.04680355 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.01041086 |
| 52 | Chest pain (HP:0100749) | 3.00440793 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.98232361 |
| 54 | Hypochromic anemia (HP:0001931) | 2.93098197 |
| 55 | Joint swelling (HP:0001386) | 2.84645578 |
| 56 | Hemoptysis (HP:0002105) | 2.82599405 |
| 57 | Gingivitis (HP:0000230) | 2.75745627 |
| 58 | Thyroiditis (HP:0100646) | 2.74908716 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.70286018 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.68542827 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.63928977 |
| 62 | Urticaria (HP:0001025) | 2.58413484 |
| 63 | Prolonged bleeding time (HP:0003010) | 2.57071441 |
| 64 | Pulmonary embolism (HP:0002204) | 2.55622784 |
| 65 | Papilledema (HP:0001085) | 2.47174737 |
| 66 | Lymphoma (HP:0002665) | 2.45433771 |
| 67 | Epistaxis (HP:0000421) | 2.45125470 |
| 68 | IgA deficiency (HP:0002720) | 2.44933564 |
| 69 | Gangrene (HP:0100758) | 2.40927897 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.39538506 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.39308266 |
| 72 | Acute hepatic failure (HP:0006554) | 2.31813369 |
| 73 | Slow saccadic eye movements (HP:0000514) | 2.30415506 |
| 74 | Hypoplasia of the thymus (HP:0000778) | 2.30408378 |
| 75 | Anorexia (HP:0002039) | 2.29431752 |
| 76 | Microcytic anemia (HP:0001935) | 2.28043650 |
| 77 | Papilloma (HP:0012740) | 2.26506578 |
| 78 | Verrucae (HP:0200043) | 2.26506578 |
| 79 | Recurrent sinusitis (HP:0011108) | 2.26415917 |
| 80 | Gingival bleeding (HP:0000225) | 2.24640638 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.19373943 |
| 82 | Arterial thrombosis (HP:0004420) | 2.18408324 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.16125342 |
| 84 | Bronchitis (HP:0012387) | 2.14914897 |
| 85 | Sepsis (HP:0100806) | 2.12110007 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11741816 |
| 87 | Glomerulopathy (HP:0100820) | 2.07060092 |
| 88 | Abnormality of the prostate (HP:0008775) | 2.06996559 |
| 89 | Cellulitis (HP:0100658) | 2.02477158 |
| 90 | Colitis (HP:0002583) | 1.99609263 |
| 91 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.93882345 |
| 92 | Petechiae (HP:0000967) | 1.93833654 |
| 93 | Episodic fever (HP:0001954) | 1.93823500 |
| 94 | Chronic otitis media (HP:0000389) | 1.92676071 |
| 95 | Basal cell carcinoma (HP:0002671) | 1.89378469 |
| 96 | Fatigue (HP:0012378) | 1.88049574 |
| 97 | Arthralgia (HP:0002829) | 1.86996450 |
| 98 | Stomach cancer (HP:0012126) | 1.86846021 |
| 99 | Skin rash (HP:0000988) | 1.84173162 |
| 100 | Abnormality of the fingertips (HP:0001211) | 1.82683662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.64131332 |
| 2 | MAP4K1 | 4.80928929 |
| 3 | RIPK4 | 2.87949200 |
| 4 | FES | 2.83821689 |
| 5 | ITK | 2.78758079 |
| 6 | CSK | 2.56042852 |
| 7 | TYK2 | 2.48194471 |
| 8 | ZAP70 | 2.35556205 |
| 9 | BTK | 2.25020506 |
| 10 | GRK6 | 2.21547120 |
| 11 | NLK | 2.15652750 |
| 12 | IKBKE | 2.14079351 |
| 13 | MAP3K13 | 2.13407308 |
| 14 | JAK3 | 2.07510247 |
| 15 | PASK | 2.06784410 |
| 16 | PRPF4B | 2.00958931 |
| 17 | LCK | 1.95435450 |
| 18 | SIK3 | 1.84608887 |
| 19 | IRAK4 | 1.84533411 |
| 20 | TEC | 1.83925399 |
| 21 | JAK1 | 1.80672828 |
| 22 | SYK | 1.79881492 |
| 23 | FGFR4 | 1.74403771 |
| 24 | HCK | 1.73197015 |
| 25 | EPHB1 | 1.69545961 |
| 26 | TAOK3 | 1.66305909 |
| 27 | CAMKK2 | 1.58439874 |
| 28 | BLK | 1.53159644 |
| 29 | MAP3K14 | 1.51711615 |
| 30 | MAP2K3 | 1.47317999 |
| 31 | TNK2 | 1.44684842 |
| 32 | CAMKK1 | 1.35784050 |
| 33 | TBK1 | 1.29611226 |
| 34 | LYN | 1.28124034 |
| 35 | STK10 | 1.25835578 |
| 36 | MARK3 | 1.22704575 |
| 37 | FGFR3 | 1.22275023 |
| 38 | MST4 | 1.13612285 |
| 39 | JAK2 | 1.11264274 |
| 40 | ERN1 | 1.01971610 |
| 41 | PRKCQ | 1.00704159 |
| 42 | MAPK11 | 1.00182303 |
| 43 | IKBKB | 0.98288018 |
| 44 | MAP3K1 | 0.96216550 |
| 45 | TYRO3 | 0.92578835 |
| 46 | EPHA3 | 0.92526095 |
| 47 | MAP3K3 | 0.92062089 |
| 48 | TAOK1 | 0.91933396 |
| 49 | MAP3K11 | 0.91117598 |
| 50 | LRRK2 | 0.89304687 |
| 51 | CSF1R | 0.88498157 |
| 52 | KSR2 | 0.84684666 |
| 53 | FGR | 0.84044687 |
| 54 | SIK2 | 0.83841902 |
| 55 | CLK1 | 0.75508630 |
| 56 | PIM1 | 0.73014985 |
| 57 | PDK1 | 0.72165992 |
| 58 | IRAK1 | 0.72147827 |
| 59 | TAOK2 | 0.70439971 |
| 60 | FYN | 0.69520493 |
| 61 | TESK2 | 0.67732333 |
| 62 | YES1 | 0.61530467 |
| 63 | HIPK2 | 0.61107064 |
| 64 | CDK4 | 0.59470598 |
| 65 | MAPK12 | 0.58254928 |
| 66 | MARK2 | 0.57695986 |
| 67 | MAP3K10 | 0.55727125 |
| 68 | GRK7 | 0.52511358 |
| 69 | PIK3CG | 0.50192904 |
| 70 | RAF1 | 0.49446199 |
| 71 | PTK6 | 0.46955062 |
| 72 | MAP3K7 | 0.46616991 |
| 73 | KIT | 0.46575295 |
| 74 | MAP3K12 | 0.43656798 |
| 75 | PDGFRB | 0.43568634 |
| 76 | CDK19 | 0.43517242 |
| 77 | TGFBR2 | 0.42746763 |
| 78 | NEK6 | 0.42636788 |
| 79 | ARAF | 0.38115030 |
| 80 | STK38 | 0.37758140 |
| 81 | BMPR2 | 0.37664371 |
| 82 | MOS | 0.35783462 |
| 83 | PRKCH | 0.35507436 |
| 84 | MAPK7 | 0.33346804 |
| 85 | MAPKAPK2 | 0.30738067 |
| 86 | MAP2K6 | 0.30030704 |
| 87 | CDK12 | 0.29040702 |
| 88 | RET | 0.29034397 |
| 89 | SGK3 | 0.27416749 |
| 90 | MAP3K5 | 0.27344717 |
| 91 | EGFR | 0.27193061 |
| 92 | DYRK1B | 0.26643271 |
| 93 | IRAK2 | 0.26322825 |
| 94 | SGK2 | 0.26075189 |
| 95 | SCYL2 | 0.25438623 |
| 96 | SIK1 | 0.24763966 |
| 97 | NTRK2 | 0.24365577 |
| 98 | BRD4 | 0.24050270 |
| 99 | SMG1 | 0.23091869 |
| 100 | CHUK | 0.22294423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.94052689 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.71574315 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.98983554 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.90133228 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.88614659 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.65377040 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.64871880 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48085839 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44223311 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20421649 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.06693829 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06334881 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98451040 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95582489 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.89535017 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85144722 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83578816 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.79813742 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.76149426 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74661679 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69686571 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.69617697 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65995752 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62440287 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56773460 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50488971 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42748836 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.40615881 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.36807128 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34042436 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32926899 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32653509 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31789698 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.31067504 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26759202 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.24817794 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20491283 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18797934 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15597518 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09373922 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.03308079 |
| 42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03065876 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.02277140 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.00876511 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.99385959 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98839706 |
| 47 | Asthma_Homo sapiens_hsa05310 | 0.97816692 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 0.95872754 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94879156 |
| 50 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94860092 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89954402 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89122289 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86462781 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85698196 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84947639 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84340141 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80617214 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76087449 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75149659 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.73229199 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72782323 |
| 62 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70878944 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70014513 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69767325 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69606589 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67681447 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.59903451 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.54608306 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53753611 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51302774 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50467685 |
| 72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49754320 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.48511373 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47007960 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.45645537 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44663058 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44278446 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.43086316 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42665324 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40081784 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39383959 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39292174 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39195096 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35419531 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34399848 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34399446 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33942402 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33932963 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33591330 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29687161 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29512509 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28265566 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23996046 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23878023 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23731839 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.21181974 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19804910 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18893804 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18821023 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.18036289 |

